Bharati Devi Kochar, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Inflammatory Bowel Diseases | 36 | 2024 | 2442 | 7.360 |
Why?
|
Colitis, Ulcerative | 18 | 2024 | 1929 | 2.740 |
Why?
|
Crohn Disease | 15 | 2024 | 2293 | 1.940 |
Why?
|
Gastrointestinal Agents | 4 | 2022 | 510 | 1.400 |
Why?
|
Proctocolectomy, Restorative | 5 | 2023 | 191 | 1.180 |
Why?
|
Internet | 3 | 2024 | 3107 | 1.010 |
Why?
|
Gastroenterology | 2 | 2022 | 589 | 0.940 |
Why?
|
Polypharmacy | 3 | 2024 | 307 | 0.930 |
Why?
|
Short Bowel Syndrome | 2 | 2018 | 353 | 0.910 |
Why?
|
Colonic Pouches | 2 | 2023 | 122 | 0.740 |
Why?
|
Depressive Disorder | 3 | 2018 | 3736 | 0.740 |
Why?
|
Pouchitis | 4 | 2023 | 64 | 0.720 |
Why?
|
Esophagitis | 1 | 2021 | 164 | 0.670 |
Why?
|
Meningitis | 1 | 2021 | 219 | 0.650 |
Why?
|
Videoconferencing | 1 | 2021 | 209 | 0.620 |
Why?
|
Pyoderma Gangrenosum | 1 | 2018 | 84 | 0.570 |
Why?
|
Telephone | 1 | 2021 | 630 | 0.570 |
Why?
|
Geriatrics | 1 | 2022 | 390 | 0.560 |
Why?
|
Opportunistic Infections | 1 | 2020 | 375 | 0.550 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 2 | 2023 | 520 | 0.550 |
Why?
|
Eosinophilic Esophagitis | 2 | 2018 | 203 | 0.520 |
Why?
|
Peptides | 2 | 2018 | 4353 | 0.500 |
Why?
|
Proton Pump Inhibitors | 2 | 2023 | 553 | 0.490 |
Why?
|
Colitis | 2 | 2020 | 1244 | 0.490 |
Why?
|
Esophageal Diseases | 1 | 2015 | 168 | 0.470 |
Why?
|
Immunocompromised Host | 1 | 2020 | 863 | 0.470 |
Why?
|
Colonic Neoplasms | 2 | 2023 | 2544 | 0.450 |
Why?
|
Exophthalmos | 1 | 2015 | 100 | 0.450 |
Why?
|
Cavernous Sinus | 1 | 2015 | 122 | 0.440 |
Why?
|
Immunologic Factors | 2 | 2021 | 1597 | 0.420 |
Why?
|
Pancreatitis | 2 | 2023 | 1087 | 0.410 |
Why?
|
Immunosuppressive Agents | 3 | 2021 | 4209 | 0.410 |
Why?
|
Pyrroles | 1 | 2018 | 1126 | 0.400 |
Why?
|
Carotid Artery, Internal | 1 | 2015 | 445 | 0.390 |
Why?
|
Mass Media | 2 | 2024 | 303 | 0.380 |
Why?
|
Arteriovenous Fistula | 1 | 2015 | 320 | 0.380 |
Why?
|
Piperidines | 2 | 2022 | 1659 | 0.370 |
Why?
|
Eosinophilia | 1 | 2015 | 556 | 0.360 |
Why?
|
Humans | 66 | 2024 | 768393 | 0.350 |
Why?
|
Quality of Life | 4 | 2024 | 13503 | 0.350 |
Why?
|
Ambulatory Care | 1 | 2021 | 2784 | 0.330 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1881 | 0.310 |
Why?
|
Aged | 24 | 2024 | 171562 | 0.310 |
Why?
|
Patient Selection | 2 | 2021 | 4266 | 0.310 |
Why?
|
Depression | 6 | 2020 | 8241 | 0.300 |
Why?
|
Thrombosis | 1 | 2022 | 2955 | 0.290 |
Why?
|
Biological Products | 3 | 2022 | 934 | 0.290 |
Why?
|
Vision Disorders | 1 | 2015 | 1093 | 0.280 |
Why?
|
Pyrimidines | 2 | 2022 | 3048 | 0.280 |
Why?
|
Colorectal Neoplasms | 3 | 2023 | 6971 | 0.270 |
Why?
|
Patient Readmission | 4 | 2024 | 3312 | 0.250 |
Why?
|
Antihypertensive Agents | 1 | 2015 | 2027 | 0.240 |
Why?
|
Cohort Studies | 8 | 2022 | 41795 | 0.230 |
Why?
|
Stents | 2 | 2023 | 3201 | 0.220 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2022 | 4357 | 0.220 |
Why?
|
Adult | 24 | 2024 | 223640 | 0.220 |
Why?
|
Abdominal Abscess | 1 | 2024 | 153 | 0.210 |
Why?
|
Telemedicine | 1 | 2021 | 3107 | 0.210 |
Why?
|
Cholinergic Antagonists | 1 | 2024 | 167 | 0.210 |
Why?
|
Parenteral Nutrition | 2 | 2018 | 663 | 0.210 |
Why?
|
Retrospective Studies | 15 | 2024 | 81801 | 0.200 |
Why?
|
Cost of Illness | 3 | 2023 | 1959 | 0.200 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5708 | 0.200 |
Why?
|
Frail Elderly | 2 | 2024 | 775 | 0.190 |
Why?
|
Prevalence | 4 | 2024 | 15872 | 0.190 |
Why?
|
Severity of Illness Index | 5 | 2024 | 15939 | 0.190 |
Why?
|
Anti-Inflammatory Agents | 2 | 2021 | 1813 | 0.190 |
Why?
|
Male | 26 | 2024 | 364902 | 0.190 |
Why?
|
Middle Aged | 20 | 2024 | 223491 | 0.190 |
Why?
|
Inappropriate Prescribing | 1 | 2024 | 213 | 0.180 |
Why?
|
Comorbidity | 5 | 2023 | 10588 | 0.180 |
Why?
|
Biological Therapy | 1 | 2022 | 140 | 0.180 |
Why?
|
Age Factors | 5 | 2024 | 18471 | 0.180 |
Why?
|
Los Angeles | 1 | 2021 | 245 | 0.180 |
Why?
|
United States | 13 | 2023 | 73150 | 0.180 |
Why?
|
Female | 27 | 2024 | 397089 | 0.170 |
Why?
|
Incidence | 6 | 2023 | 21544 | 0.170 |
Why?
|
Registries | 1 | 2016 | 8379 | 0.170 |
Why?
|
Treatment Outcome | 9 | 2024 | 65379 | 0.160 |
Why?
|
Insurance, Life | 1 | 2018 | 14 | 0.160 |
Why?
|
Anastomosis, Surgical | 2 | 2022 | 993 | 0.160 |
Why?
|
Young Adult | 11 | 2024 | 60049 | 0.160 |
Why?
|
Flatulence | 1 | 2017 | 19 | 0.150 |
Why?
|
Health Care Costs | 2 | 2023 | 3267 | 0.150 |
Why?
|
Histocytochemistry | 1 | 2018 | 699 | 0.140 |
Why?
|
Feces | 1 | 2024 | 1512 | 0.140 |
Why?
|
Risk Factors | 9 | 2024 | 74962 | 0.140 |
Why?
|
Postoperative Complications | 2 | 2024 | 15881 | 0.140 |
Why?
|
Denmark | 1 | 2019 | 779 | 0.140 |
Why?
|
Insurance | 1 | 2018 | 115 | 0.140 |
Why?
|
Gases | 1 | 2017 | 204 | 0.140 |
Why?
|
Syndrome | 1 | 2023 | 3275 | 0.140 |
Why?
|
Pancreatic Diseases | 1 | 2018 | 353 | 0.130 |
Why?
|
Aged, 80 and over | 6 | 2021 | 59686 | 0.130 |
Why?
|
Hospitalization | 4 | 2024 | 10844 | 0.130 |
Why?
|
Time Factors | 6 | 2021 | 40272 | 0.120 |
Why?
|
Social Participation | 1 | 2017 | 187 | 0.120 |
Why?
|
Levobunolol | 1 | 2015 | 3 | 0.120 |
Why?
|
Drug Utilization | 1 | 2021 | 1191 | 0.120 |
Why?
|
Anti-Bacterial Agents | 2 | 2024 | 7463 | 0.120 |
Why?
|
Fecal Incontinence | 1 | 2017 | 246 | 0.120 |
Why?
|
Liver Cirrhosis | 2 | 2022 | 1959 | 0.120 |
Why?
|
Nausea | 1 | 2017 | 682 | 0.120 |
Why?
|
Multivariate Analysis | 4 | 2021 | 12092 | 0.120 |
Why?
|
Anxiety | 3 | 2020 | 4677 | 0.110 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 26375 | 0.110 |
Why?
|
Dilatation | 1 | 2015 | 313 | 0.110 |
Why?
|
Esophagoscopy | 1 | 2015 | 398 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2023 | 10377 | 0.110 |
Why?
|
Ophthalmic Solutions | 1 | 2015 | 312 | 0.110 |
Why?
|
Adolescent | 12 | 2024 | 89184 | 0.110 |
Why?
|
Logistic Models | 4 | 2021 | 13323 | 0.110 |
Why?
|
Personal Satisfaction | 1 | 2017 | 647 | 0.100 |
Why?
|
Quinoxalines | 1 | 2015 | 297 | 0.100 |
Why?
|
Antibodies | 1 | 2021 | 2425 | 0.100 |
Why?
|
Constipation | 1 | 2017 | 570 | 0.100 |
Why?
|
Regression Analysis | 2 | 2021 | 6350 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1890 | 0.100 |
Why?
|
Digestive System Surgical Procedures | 1 | 2017 | 584 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2021 | 4859 | 0.100 |
Why?
|
Deglutition Disorders | 1 | 2017 | 641 | 0.090 |
Why?
|
Abdominal Pain | 1 | 2017 | 1070 | 0.090 |
Why?
|
Risk Assessment | 2 | 2024 | 24318 | 0.090 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39407 | 0.090 |
Why?
|
Information Storage and Retrieval | 1 | 2016 | 824 | 0.090 |
Why?
|
Medical Records | 1 | 2016 | 1412 | 0.090 |
Why?
|
Diarrhea | 1 | 2017 | 1320 | 0.090 |
Why?
|
Thiophenes | 1 | 2015 | 569 | 0.090 |
Why?
|
Minority Groups | 1 | 2017 | 1215 | 0.090 |
Why?
|
Steroids | 1 | 2015 | 937 | 0.090 |
Why?
|
Fatigue | 1 | 2017 | 1555 | 0.090 |
Why?
|
Age of Onset | 1 | 2017 | 3345 | 0.090 |
Why?
|
Liver Diseases | 1 | 2018 | 1304 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1207 | 0.080 |
Why?
|
Gastroesophageal Reflux | 1 | 2017 | 835 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 13020 | 0.080 |
Why?
|
Remission Induction | 1 | 2015 | 2407 | 0.080 |
Why?
|
Odds Ratio | 2 | 2021 | 9682 | 0.080 |
Why?
|
Cerebral Angiography | 1 | 2015 | 1274 | 0.080 |
Why?
|
Intraocular Pressure | 1 | 2015 | 1304 | 0.080 |
Why?
|
Intestines | 1 | 2017 | 1912 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2021 | 22296 | 0.080 |
Why?
|
Hyperplasia | 2 | 2021 | 1153 | 0.070 |
Why?
|
Cognition | 2 | 2023 | 7075 | 0.070 |
Why?
|
Reoperation | 1 | 2018 | 4341 | 0.070 |
Why?
|
Ileum | 2 | 2023 | 558 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2019 | 2913 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12558 | 0.070 |
Why?
|
Health Status | 1 | 2020 | 4094 | 0.070 |
Why?
|
Self Report | 1 | 2017 | 3766 | 0.060 |
Why?
|
Disease Progression | 1 | 2023 | 13646 | 0.060 |
Why?
|
Health Expenditures | 1 | 2018 | 2395 | 0.060 |
Why?
|
Recurrence | 1 | 2017 | 8506 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16721 | 0.060 |
Why?
|
Sulfonamides | 1 | 2015 | 1980 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11120 | 0.060 |
Why?
|
Skin | 1 | 2018 | 4499 | 0.060 |
Why?
|
Prognosis | 4 | 2019 | 30022 | 0.060 |
Why?
|
Prospective Studies | 5 | 2023 | 54920 | 0.060 |
Why?
|
Smoking | 1 | 2021 | 9111 | 0.060 |
Why?
|
Geriatric Assessment | 2 | 2022 | 1422 | 0.060 |
Why?
|
Length of Stay | 1 | 2017 | 6519 | 0.060 |
Why?
|
Colonoscopy | 2 | 2021 | 1412 | 0.050 |
Why?
|
Medicare | 1 | 2021 | 6881 | 0.050 |
Why?
|
Child, Preschool | 3 | 2022 | 42650 | 0.050 |
Why?
|
Quality Improvement | 1 | 2018 | 3858 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3413 | 0.050 |
Why?
|
I-kappa B Proteins | 1 | 2002 | 210 | 0.050 |
Why?
|
Colon | 2 | 2023 | 1805 | 0.050 |
Why?
|
Child | 5 | 2020 | 80891 | 0.050 |
Why?
|
Metagenome | 1 | 2024 | 465 | 0.040 |
Why?
|
Research Design | 1 | 2016 | 6210 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2020 | 26411 | 0.040 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 299 | 0.040 |
Why?
|
Biopsy | 2 | 2021 | 6808 | 0.040 |
Why?
|
Cholangitis, Sclerosing | 1 | 2021 | 179 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15455 | 0.040 |
Why?
|
Infant | 1 | 2020 | 36510 | 0.040 |
Why?
|
Independent Living | 1 | 2022 | 580 | 0.040 |
Why?
|
Diet | 1 | 2015 | 8090 | 0.040 |
Why?
|
Administration, Oral | 1 | 2024 | 4039 | 0.030 |
Why?
|
Phylogeny | 1 | 2024 | 2843 | 0.030 |
Why?
|
Hospital Charges | 1 | 2017 | 351 | 0.030 |
Why?
|
NF-kappa B | 1 | 2002 | 2489 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2002 | 2886 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2016 | 948 | 0.030 |
Why?
|
Acute Disease | 1 | 2024 | 7242 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2023 | 1901 | 0.030 |
Why?
|
Bacteria | 1 | 2024 | 2221 | 0.030 |
Why?
|
Needs Assessment | 1 | 2018 | 1142 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2021 | 3731 | 0.020 |
Why?
|
Databases, Factual | 2 | 2017 | 8075 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6085 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3135 | 0.020 |
Why?
|
Patient Discharge | 1 | 2024 | 3476 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2017 | 924 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20765 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2018 | 1407 | 0.020 |
Why?
|
Neutrophils | 1 | 2002 | 3785 | 0.020 |
Why?
|
Genotype | 1 | 2024 | 13042 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2022 | 7145 | 0.020 |
Why?
|
Insurance, Health | 1 | 2021 | 2518 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9379 | 0.020 |
Why?
|
Apoptosis | 1 | 2002 | 9516 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10654 | 0.020 |
Why?
|
Animals | 1 | 2018 | 169337 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 9614 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7861 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10863 | 0.010 |
Why?
|
Neutrophil Activation | 1 | 2002 | 180 | 0.010 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2002 | 432 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5512 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9510 | 0.010 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2002 | 542 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11918 | 0.010 |
Why?
|
Cytoplasm | 1 | 2002 | 1502 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 12778 | 0.010 |
Why?
|
Monocytes | 1 | 2002 | 2595 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2002 | 19022 | 0.000 |
Why?
|